BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Le Z, He Z, Liu H, Liu L, Liu Z, Chen Y. Antioxidant Enzymes Sequestered within Lipid-Polymer Hybrid Nanoparticles for the Local Treatment of Inflammatory Bowel Disease. ACS Appl Mater Interfaces 2021;13:55966-77. [PMID: 34792322 DOI: 10.1021/acsami.1c19457] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Vaghari-tabari M, Alemi F, Zokaei M, Moein S, Qujeq D, Yousefi B, Farzami P, Hosseininasab SS. Polyphenols and inflammatory bowel disease: Natural products with therapeutic effects? Critical Reviews in Food Science and Nutrition 2022. [DOI: 10.1080/10408398.2022.2139222] [Reference Citation Analysis]
2 Le Z, Yu J, Quek YJ, Bai B, Li X, Shou Y, Myint B, Xu C, Tay A. Design principles of microneedles for drug delivery and sampling applications. Materials Today 2022. [DOI: 10.1016/j.mattod.2022.10.025] [Reference Citation Analysis]
3 Subramanian DA, Langer R, Traverso G. Mucus interaction to improve gastrointestinal retention and pharmacokinetics of orally administered nano-drug delivery systems. J Nanobiotechnology 2022;20:362. [PMID: 35933341 DOI: 10.1186/s12951-022-01539-x] [Reference Citation Analysis]
4 Li DF, Yang MF, Xu HM, Zhu MZ, Zhang Y, Tian CM, Nie YQ, Wang JY, Liang YJ, Yao J, Wang LS. Nanoparticles for oral delivery: targeted therapy for inflammatory bowel disease. J Mater Chem B 2022. [PMID: 35876136 DOI: 10.1039/d2tb01190e] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Le Z, He Z, Liu H, Ke J, Liu L, Liu Z, Chen Y. Orally administrable polyphenol-based nanoparticles achieve anti-inflammation and antitumor treatment of colon diseases. Biomater Sci 2022. [PMID: 35726761 DOI: 10.1039/d2bm00540a] [Reference Citation Analysis]
6 Xu C, Chen S, Chen C, Ming Y, Du J, Mu J, Luo F, Huang D, Wang N, Lin Z, Weng Z. Colon-targeted oral nanoparticles based on ROS-scavenging hydroxyethyl starch-curcumin conjugates for efficient inflammatory bowel disease therapy. Int J Pharm 2022;623:121884. [PMID: 35661797 DOI: 10.1016/j.ijpharm.2022.121884] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
7 Watchorn J, Clasky AJ, Prakash G, Johnston IAE, Chen PZ, Gu FX. Untangling Mucosal Drug Delivery: Engineering, Designing, and Testing Nanoparticles to Overcome the Mucus Barrier. ACS Biomater Sci Eng 2022;8:1396-426. [PMID: 35294187 DOI: 10.1021/acsbiomaterials.2c00047] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]